Ambarella Inc (NASDAQ: AMBA) has reported E.P.S. of $-1.50 for its fourth fiscal quarter (ending January 31) versus $-0.29 for the same period a year ago. Relative to the consensus estimate of $-0.33, this was […]
Ambac Financial Group Inc (NYSE: AMBC) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.24 versus $3.93 for the same period a year ago — a decline of -106%. This […]
For its fourth fiscal quarter (ending December 31), Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported E.P.S. of $0.28 compared to $-0.26 a year ago. This result fell short of the consensus estimate of $0.31 by […]
Pinnacle West Capital Corp (NYSE: PNW) has reported E.P.S. of $0.00 for its fourth fiscal quarter (ending December 31) versus $-0.21 for the same period a year ago. This performance was $0.13 better than the […]
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.36 for its fourth fiscal quarter (ending December 31) versus $-0.52 for the same period a year ago. Relative to the consensus estimate of $0.01, this […]
For its fourth fiscal quarter (ending December 31), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported E.P.S. of $1.04 compared to $-0.86 a year ago. This performance was $0.38 better than the consensus estimate of $0.66. […]
ICF International Inc (NASDAQ: ICFI) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.18 versus $0.47 for the same period a year ago — an increase of 151%. However, this result […]
HENRY SCHEIN INC (NASDAQ: HSIC) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.13 versus $0.35 for the same period a year ago — a decline of -63%. Relative to the […]
Recent significant negative changes in fundamentals have impacted GeoPark Ltd (NYSE: GPRK): the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Recent […]
Extremely important negative changes in investment behavior have recently occurred for Finward Bancorp (NASDAQ: FNWD): negative upside/downside volume developed, and its shorter term price trend turned down. Finward Bancorp (NASDAQ: FNWD). Important negative changes in […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research